Pancreatic Cancer

About Pancreatic Cancer

At Penn Medicine, patients with pancreatic cancer receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gastrointestinal cancer.

Pancreatic cancer is cancer that develops within the pancreas, the gland about six inches long that is responsible for making hormones, including the enzymes responsible for the digestion of food and control of blood sugar.

Pancreatic cancer develops when cells within the pancreas begin to grow out of control. It may spread, or metastasize, to nearby lymph nodes and organs such as the liver and lungs.

The pancreas has three sections:

  • Head: Part of the pancreas adjacent to the small bowel and liver ducts
  • Body: Middle of the pancreas
  • Tail: End of the pancreas near the spleen

About 90 percent or more of pancreatic cancer develops in the head of the pancreas.

Penn Medicine's multidisciplinary approach to cancer diagnosis and treatment provides better outcomes and gives patients access to the most advanced treatment, surgical techniques and clinical trials.

Because navigating a new cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them simplify entry into Penn and make an appointment with the right physician.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).

Read more About Pancreatic Cancer

Diagnosing Pancreatic Cancer

An accurate cancer diagnosis from trusted cancer specialists is the first step in getting personalized treatment options to treat pancreatic cancer.

Patients who choose Penn's Abramson Cancer Center, benefit from a multidisciplinary team of cancer specialists including gastroenterologists, radiologists, pathologists and surgeons who work together to provide both a diagnosis and treatment plan individualized for each patient with pancreatic cancer.

Cancer specialists at Penn Medicine are highly experienced in using the most advanced techniques for diagnosing pancreatic cancer and are actively researching better and more precise ways to detect pancreatic cancer.

Because an accurate diagnosis is an important step in planning cancer treatment, it's important patients know that when they come to Penn Medicine, they are taking an important step in getting the best cancer treatment.

Navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right person. Penn Medicine's contact center has experienced cancer nurses available and ready to guide patients in finding the cancer specialist right for them.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).

Read more Diagnosing Pancreatic Cancer

Pancreatic Cancer Treatments

Following the diagnosis and staging of pancreatic cancer, cancer specialists at Penn Medicine's Abramson Cancer Center develop a personalized treatment plan. Penn's treatment options for pancreatic cancer include:

  • Surgery
    • Whipple procedure
    • Pylorus-sparing Whipple
    • Total pancreatectomy
    • Distal pancreatectomy
    • Enucleation (for certain rare types of cancer)
  • Palliative surgery
    • Surgical biliary drainage
    • Endoscopic stent placement for bilary drainage
    • Endonsocoic stent placement for gastric outlet obstuction
    • Surgical gastrojejunostomy
  • Radiation therapy
    • Three-dimensional conformal radiation therapy
    • Intensity-modulated radiation therapy (IMRT)
    • Proton therapy
    • Volumetric-modulated arc therapy (VMAT)
  • Chemotherapy and biologic therapies
    • Photodynamic Therapy (PDT)
  • Clinical trials
  • Other treatments
    • Integrative medicine and wellness
    • Palliative care
    • Penn Home Care and Hospice

Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the correct cancer specialist.

To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN.

Read more Pancreatic Cancer Treatments

Pancreatic Cancer Survivorship

Survivorship programs at Penn Medicine are a distinct phase of pancreatic cancer care and are designed to help patients' transition from their cancer treatment routine to a post-cancer care lifestyle. There are more than 12 million cancer survivors living and thriving today as a result of advances in cancer treatment. However, cancer treatments can result in physical, emotional and financial complications long after the therapy is complete.

Read more Pancreatic Cancer Survivorship


Frank McKee

Proton Therapy Treatment for Prostate Cancer

Watch CANPrevent Colorectal Cancer Conference to learn about your risk for developing colorectal cancer.

Watch Focus on Gastrointestinal Cancers Conference - Get information on the latest advances in gastrointestinal cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.

Watch Focus On Pancreatic Cancer Conference - Get information on the latest advances in pancreatic cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.

Watch the Focus On Neuroendocrine Tumors Conference

NBC10 Colorectal Cancer Awareness Month
Video with Dr. Gregory Ginsberg

OncoLink's" The Basics" -- Learn basic information about different gastrointestinal cancers.

 

OncoLink - Advances in Colorectal Cancer Screening. Read OncoLink's brown bag chat transcript.

Clinical Briefing: Management of Neuroendocrine Tumors

Abramson Cancer Centers Gastrointestinal Cancer Program is conducting exciting, innovation research entitled "The Mechanisms of Esophageal Carcinogenesis." This important project will define underlying mechanisms in the development of esophageal cancer that will lead to new ways to diagnose and treat this cancer. Find out more...



Clinical Trials

Pancreatic Cancer Trials

A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to... more


myPennMedicine